Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Yao, Jian ^a   Morioka, Tetsuo ^a   Li, Bing ^a   Oite, Takashi ^a,b  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata University   (Japan)

Author keywords

Cytochalasin D; Cytokines; Endothelin receptor antagonist; Tissue inhibitor of matrix metalloproteinase 2; Zymography

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; CYTOCHALASIN D; CYTOKINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; GAMMA INTERFERON; GELATINASE A; LIPOPOLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GLOMERULUS; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZYMOGRAPHY;

EID: 0035009182     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.4.f628     Document Type: Article

References (42)

1. Allenberg M and Silverman M. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem J 313: 879-884, 1996.
2. Allenberg M, Weinstein T, Li I, and Silverman M. Activation of procollagenase IV by cytochalasin D and concanavalin A in cultured rat mesangial cells: linkage to cytoskeletal reorganization. J Am Soc Nephrol 4: 1760-1770, 1994.
3. Baricos WH, Cortez SL, Deboisblanc M, and Xin S. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 10: 790-795, 1999.
4. Baricos WH, Cortez SL, El-Dahr SS, and Schnaper HW. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47: 1039-1047, 1995.
5. Benigni A and Remuzzi G. Endothelin antagonists. Lancet 353: 133-138, 1999.
6. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, and Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44: 440-444, 1993.
7. Bruzzi I and Benigni A. Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategies. Clin Exp Pharmacol Physiol 23: 349-353, 1996.
8. Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, and Benigni A. Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 151: 1241-1247, 1997.
9. Bruzzi I, Remuzzi G, and Benigni A. Endothelin: a mediator of renal disease progression. J Nephrol 10: 179-183, 1997.
10. Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today 4: 130-137, 1998.
11. Coker ML, Doscher MA, Thomas CV, Galis ZS, and Spinale FG. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol Heart Circ Physiol 277: H777-H787, 1999.
12. Davies M, Martin J, Thomas GJ, and Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int 41: 671-678, 1992.
13. Davies M, Thomas GJ, Martin J, and Lovett DH. The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells. Biochem J 251: 419-425, 1988.
14. Del Prete D, Anglani F, Forino M, Ceol M, Fioretto P, Nosadini R, Baggio B, and Gambaro G. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia 40: 1449-1454, 1997.
15. Fernandez-Patron C, Radomski MW, and Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85: 906-911, 1999.
16. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, and Koide H. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122: 149-156, 1993.
17. Gomez-Garre D, Largo R, Liu XH, Gutierrez S, Lopez-Armada MJ, Palacios I, and Egido J. An orally active ETA/ ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int 50: 962-972, 1996.
18. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, and Egido J. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27: 885-892, 1996.
19. Guarda E, Katwa LC, Myers PR, Tyagi SC, and Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiouasc Res 27: 2130-2134, 1993.
20. Hayashi K, Osada S, Shofuda K, Horikoshi S, Shirato I, and Tomino Y. Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9: 2262-2271, 1998.
21. Iwamoto T, Tamaki K, Nakayama M, Okuda S, and Fujishima M. Effect of endothelin 1 on fibrinolysis and plasminogen activator inhibitor 1 synthesis in rat mesangial cells. Nephron 73: 273-279, 1996.
22. Kohan DE. Production of endothelin-1 by rat mesangial cells: regulation by tumor necrosis factor. J Lab Clin Med 119: 477-484, 1992.
23. Kohan DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis 22: 493-510, 1993.
24. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26, 1997.
25. Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE, and Striker LJ. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 48: 1638-1644, 1999.
26. Marti HP, Lee L, Kashgarian M, and Lovett DH. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 144: 82-94, 1994.
27. Marti HP, McNeil L, Davies M, Martin J, and Lovett DH. Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem J 291: 441-446, 1993.
28. Martin J, Davies M, Thomas G, and Lovett DH. Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 36: 790-801, 1989.
29. Martin J, Lovett DH, Gemsa D, Sterzel RB, and Davies M. Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1. J Immunol 137: 525-529, 1986.
30. Martin J, Steadman R, Knowlden J, Williams J, and Davies M. Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro. J Am Soc Nephrol 9: 1629-1637, 1998.
31. Mo W, Brecklin C, Garber SL, Song RH, Pegoraro AA, Au J, Arruda JA, Dunea G, and Singh AK. Changes in collagenases and TGF-β precede structural alterations in a model of chronic renal fibrosis. Kidney Int 56: 145-153, 1999.
32. Oite T, Saito M, Suzuki Y, Arii T, Morioka T, and Shimizu F. A specific Thy-1 molecular epitope expressed on rat mesangial cells. Exp Nephrol 4: 350-360, 1996.
33. Okumura Y, Sato H, Seiki M, and Kido H. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett 402: 181-184, 1997.
34. Poncelet AC and Schnaper HW. Regulation of human mesangial cell collagen expression by transforming growth factor-β1. Am J Physiol Renal Physiol 275: F458-F466, 1998.
35. Rupprecht HD, Schocklmann HO, and Sterzel RB. Cell-matrix interactions in the glomerular mesangium. Kidney Int 49: 1575-1582, 1996.
36. Sakamoto H, Sasaki S, Hirata Y, Imai T, Ando K, Ida T, Sakurai T, Yanagisawa M, Masaki T, and Marumo F. Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 169: 462-468, 1990.
37. Song RH, Singh AK, and Leehey DJ. Decreased glomerular proteinase activity in the streptozotocin diabetic rat. Am J Nephrol 19: 441-446, 1999.
38. Trachtman H, Futterweit S, Garg P, Reddy K, and Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 218: 704-708, 1996.
39. Turck J, Pollock AS, Lee LK, Marti HP, and Lovett DH. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271: 15074-15083, 1996.
40. Yao J, Morioka T, and Oite T. PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells. Kidney Int 57(5): 1915-1926, 2000.
41. Yao J, Schoecklmann HO, Prols F, Gauer S, and Sterzel RB. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components. Kidney Int 53: 598-608, 1998.
42. 2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int 51: 1116-1123, 1997.